‘Rewarding terror’: Netanyahu slams Albo - Yahoo News Australia
Yesterday • Google News
Albireo Pharma Inc (ALBO)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 915.89M
P/E Ratio
0.00
Revenue (TTM)
$ 57.39M
Volume
0
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.04
Technicals
50-Day MA
38.9606
200-Day MA
25.2978
52 Week High
N/A
52 Week Low
N/A
About ALBO
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other li.
Employees
130
Headquarters
Boston, MA
CEO
Mr. Ronald H. W. Cooper